WuXi XDC
WuXi XDC is the largest dedicated ADC CDMO, spun out of WuXi Biologics and listed in Hong Kong in 2023; it is exposed to US BIOSECURE Act politics.
Integrated antibody, payload-linker, conjugation, and fill-finish services; a large share of the world's clinical ADCs are made here; building a Singapore site to diversify from China.
Pages like this
not linked directly; found by shared links- CompanyPiramal Pharma Solutions
Shares Payload-linker synthesis (high-potency API), ADC bioconjugation manufacturing (CDMOs) and the tag supporting.
- CompanyMGI Tech
Shares BIOSECURE Act and the tag supporting.
- CompanyLonza
Shares Payload-linker synthesis (high-potency API), ADC bioconjugation manufacturing (CDMOs) and the tag supporting.
- CompanyAbzena
Shares ADC bioconjugation manufacturing (CDMOs) and the tag supporting.
- CompanySamsung Biologics
Shares ADC bioconjugation manufacturing (CDMOs) and the tag supporting.
- TechnologyNew short-read sequencing platforms
Shares BIOSECURE Act and the tag supporting.
- TechnologyAntibody manufacturing (CHO bioprocessing)
Shares ADC bioconjugation manufacturing (CDMOs) and the tag supporting.